SecBot SecBot

CLDWW

Calidi Biotherapeutics, Inc.
OTC· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001855485 Biotech & Drug Discovery
—
Filing reports
2
analyzed by SecBot
SecBot read MIXED 2 reports · latest
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/2
Strongest NEUTRAL Calidi Biotherapeutics issued an amended and restated warrant to purchase up to 17,391,304 shares of common…
All reports →

Price

Daily candles with volume.

Who's buying

13F
Top holderSharesValue
DRIEHAUS CAPITAL MANAGEMENT LLC750,000$9.3K
NOMURA HOLDINGS INC467,818$6.1K
MILLENNIUM MANAGEMENT LLC100,500$1.3K
CITADEL ADVISORS LLC70,701$926.00
Walleye Capital LLC36,469$478.00
Walleye Trading LLC20,052$263.00
UBS Group AG5,398$70.00

Quarterly 13F filings are due 45 days after each quarter ends.

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
May 29, 2026 SEC
Calidi Biotherapeutics issued an amended and restated warrant to purchase up to 17,391,304 shares of common stock at…
8-K — Impact 4/10
May 8, 2026 SEC
Calidi Biotherapeutics issued a warrant to an accredited investor to purchase up to 17,391,304 shares at $0.23 per…
8-K — Impact 4/10

SecBot reports

2 filings · 0 bullish · 0 bearish · 2 neutral
All CLDWW filing & press-release reports (2)